Globus Medical is a medical device company that develops products for patients with musculoskeletal disorders. The firm's products are organized into two categories: innovative fusion and disruptive technologies. The innovative fusion products include fusion products that treat a variety of spinal disorders and can be used in several surgical applications. The disruptive technology products are used for applications such as minimally invasive surgery and new treatment alternatives, including motion preservation and regenerative biologic technologies. Globus Medical generates the vast majority of its revenue in the United States.
| Website: | www.globusmedical.com |
| Email: | investors@globusmedical.com |
| Main Phone: | +1 610 930-1800 |
| Address: | 2560 General Armistead Avenue |
| State: | PA |
| City / Town: | Audubon |
| Country: | USA |
| Postal Code: | 19403 |
| Exchange: | NYE |
| CEO: | David M. Demski |
| Employees: | 1800 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
As a sector, medical robotics has the potential to be a leader in the entire automation space.
With the Patient Protection and Affordable Care Act less than six months away from full implementation, there has been a great deal of talk about how various sectors of the healthcare industry
The S&P Case Shiller Home Price Index (the 20-City Composite) rose 0.5% year over year in June, up 2.3% versus May and posted a quarter over quarter gain of 6.0%. The Conference Board’s
The Dow Jones Industrial Average opened higher, traded down to 13,121.65 then up to 13,176.17. The NASDAQ opened higher, traded down to 3069.05 then up to 3085.81. Asian stocks were mixed on
US stock futures are unchanged this morning as investors remain cautiously optimistic about Europe and continue to digest corporate earnings. Tomorrow, European leaders will once again convene to
Gathering Data... Please wait Globus Medical is a medical device company that develops products for patients with musculoskeletal disorders. The firm's products are organized into two categories: innovative fusion and disruptive technologies. The innovative fusion products include fusion products that treat a variety of spinal disorders and can be used in several surgical applications. The disruptive technology products are used for applications such as minimally invasive surgery and new treatment alternatives, including motion preservation and regenerative biologic technologies. Globus Medical generates the vast majority of its revenue in the United States.
| Website: | www.globusmedical.com |
| Email: | investors@globusmedical.com |
| Main Phone: | +1 610 930-1800 |
| Address: | 2560 General Armistead Avenue |
| State: | PA |
| City / Town: | Audubon |
| Country: | USA |
| Postal Code: | 19403 |
| Exchange: | NYE |
| CEO: | David M. Demski |
| Employees: | 1800 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
As a sector, medical robotics has the potential to be a leader in the entire automation space.
With the Patient Protection and Affordable Care Act less than six months away from full implementation, there has been a great deal of talk about how various sectors of the healthcare industry
The S&P Case Shiller Home Price Index (the 20-City Composite) rose 0.5% year over year in June, up 2.3% versus May and posted a quarter over quarter gain of 6.0%. The Conference Board’s
The Dow Jones Industrial Average opened higher, traded down to 13,121.65 then up to 13,176.17. The NASDAQ opened higher, traded down to 3069.05 then up to 3085.81. Asian stocks were mixed on
US stock futures are unchanged this morning as investors remain cautiously optimistic about Europe and continue to digest corporate earnings. Tomorrow, European leaders will once again convene to
| Last Price 50.46 | Change $ 1.01 | Change % 2.04 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 50.05 | High 51.14 | Low 49.21 | Prev Close 49.45 |
| Last Trade | Volume 346,380 | 52 Wk Hi 57.83 | 52 Wk Low 38.01 |
| Market Cap 5 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 99,100,509.00 | EPS (TTM) 1.42 | PE Ratio 35.00 | Exchange NYSE |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 70 | 110 |
| Number of Buys | 22 | 42 |
| Number of Sells | 48 | 68 |
| Net Activity | -1171775 | -812734 |
| Last 10 Buys | Shares |
|---|---|
| N/A | 0 |
| Last 10 Sell | Shares |
|---|---|
| Steven M. Payne | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 65 | 60 | 60 | 65 |
| Low Target Price Estimate | 37 | 37 | 37 | 37 |
| Mean Target Price Estimate | 55.78 | 54.5 | 54.5 | 55.78 |
| Standard Deviation | 7.97 | 7.56 | 7.56 | 7.97 |
| Date of Most Recent Estimate | 06/01/18 | 05/04/18 | 05/04/18 | 06/01/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| SD | Specialized Disclosure Report | 3 | 2018-05-30 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 43 | 2018-05-03 |
| 8-K | Report of unscheduled material events or corporate changes. | 12 | 2018-05-02 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-30 |
| DEFA14A | Additional proxy soliciting materials - definitive | 4 | 2018-04-26 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 51 | 2018-04-26 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-20 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 4 | 7 | 7 |
| Moderate Buy | 1 | 1 | 1 | 0 |
| Hold | 4 | 5 | 4 | 4 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 1 |
| Mean Rec. | 1.9 | 2.1 | 1.75 | 2 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
